BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22300262)

  • 1. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
    Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA
    Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of eicosapentaenoic acid on E-type prostaglandin synthesis and EP4 receptor signaling in human colorectal cancer cells.
    Hawcroft G; Loadman PM; Belluzzi A; Hull MA
    Neoplasia; 2010 Aug; 12(8):618-27. PubMed ID: 20689756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Volpato M; Ingram N; Perry SL; Spencer J; Race AD; Marshall C; Hutchinson JM; Nicolaou A; Loadman PM; Coletta PL; Hull MA
    Cancer Chemother Pharmacol; 2021 Feb; 87(2):173-184. PubMed ID: 33040178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.
    Cockbain AJ; Volpato M; Race AD; Munarini A; Fazio C; Belluzzi A; Loadman PM; Toogood GJ; Hull MA
    Gut; 2014 Nov; 63(11):1760-8. PubMed ID: 24470281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice.
    Fini L; Piazzi G; Ceccarelli C; Daoud Y; Belluzzi A; Munarini A; Graziani G; Fogliano V; Selgrad M; Garcia M; Gasbarrini A; Genta RM; Boland CR; Ricciardiello L
    Clin Cancer Res; 2010 Dec; 16(23):5703-11. PubMed ID: 21030497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.
    Volpato M; Perry SL; Marston G; Ingram N; Cockbain AJ; Burghel H; Mann J; Lowes D; Wilson E; Droop A; Randerson-Moor J; Coletta PL; Hull MA
    Oncotarget; 2016 May; 7(19):28139-50. PubMed ID: 27058904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.
    Piazzi G; D'Argenio G; Prossomariti A; Lembo V; Mazzone G; Candela M; Biagi E; Brigidi P; Vitaglione P; Fogliano V; D'Angelo L; Fazio C; Munarini A; Belluzzi A; Ceccarelli C; Chieco P; Balbi T; Loadman PM; Hull MA; Romano M; Bazzoli F; Ricciardiello L
    Int J Cancer; 2014 Nov; 135(9):2004-13. PubMed ID: 24676631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway.
    Calviello G; Di Nicuolo F; Gragnoli S; Piccioni E; Serini S; Maggiano N; Tringali G; Navarra P; Ranelletti FO; Palozza P
    Carcinogenesis; 2004 Dec; 25(12):2303-10. PubMed ID: 15358633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol.
    Hull MA; Ow PL; Ruddock S; Brend T; Smith AF; Marshall H; Song M; Chan AT; Garrett WS; Yilmaz O; Drew DA; Collinson F; Cockbain AJ; Jones R; Loadman PM; Hall PS; Moriarty C; Cairns DA; Toogood GJ
    BMJ Open; 2023 Nov; 13(11):e077427. PubMed ID: 38030258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylation.
    Yang P; Cartwright C; Chan D; Ding J; Felix E; Pan Y; Pang J; Rhea P; Block K; Fischer SM; Newman RA
    Mol Carcinog; 2014 Jul; 53(7):566-77. PubMed ID: 23371504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
    D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
    Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K; Han C; Dai Y; Shen M; Wu T
    Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krill oil extract suppresses cell growth and induces apoptosis of human colorectal cancer cells.
    Jayathilake AG; Senior PV; Su XQ
    BMC Complement Altern Med; 2016 Aug; 16(1):328. PubMed ID: 27576529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E3 metabolism and cancer.
    Yang P; Jiang Y; Fischer SM
    Cancer Lett; 2014 Jun; 348(1-2):1-11. PubMed ID: 24657656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms.
    Stolfi C; Franzè E; Monteleone I; Caruso R; Franceschilli L; Sileri P; Sica GS; Gaspari AL; Del Vecchio Blanco G; Pallone F; Monteleone G
    Clin Sci (Lond); 2012 Sep; 123(5):295-306. PubMed ID: 22435743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.
    Watson H; Cockbain AJ; Spencer J; Race A; Volpato M; Loadman PM; Toogood GJ; Hull MA
    Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():60-66. PubMed ID: 27914515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
    Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
    Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cyclooxygenase in n-6 and n-3 polyunsaturated fatty acid mediated effects on cell proliferation, PGE(2) synthesis and cytotoxicity in human colorectal carcinoma cell lines.
    Dommels YE; Haring MM; Keestra NG; Alink GM; van Bladeren PJ; van Ommen B
    Carcinogenesis; 2003 Mar; 24(3):385-92. PubMed ID: 12663496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
    Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
    Trials; 2013 Jul; 14():237. PubMed ID: 23895505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.